Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine
Clinical trial NCT00805389 · COMPLETED
Trial details
- NCT number
- NCT00805389
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-15
- Primary completion
- 2010-09-29
- Enrollment
- 713
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.